Ad M. Gillis

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Reply to: Time-Varying Effects of Copy Number Alteration Clustering: Methodologic Concerns in Survival Analysis of Relapsed/Refractory Germ Cell Tumors.

Reply to: Time-Varying Effects of Copy Number Alteration Clustering: Methodologic Concerns in Survival Analysis of Relapsed/Refractory Germ Cell Tumors.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 27, 2026

Impact of Circulating Tumor DNA and Copy-Number Alterations on Clinical Outcome in Relapsed/Refractory Germ Cell Tumors Treated With Salvage High-Dose Chemotherapy.

Impact of Circulating Tumor DNA and Copy-Number Alterations on Clinical Outcome in Relapsed/Refractory Germ Cell Tumors Treated With Salvage High-Dose Chemotherapy.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 19, 2026

Identification and validation of liquid biopsy-based methylation biomarkers for germ cell tumor subtypes.

Identification and validation of liquid biopsy-based methylation biomarkers for germ cell tumor subtypes.

Journal: Communications medicine

Published: August 22, 2025

Depletion of TP53 in Human Pluripotent Stem Cells Triggers Malignant-Like Behavior.

Depletion of TP53 in Human Pluripotent Stem Cells Triggers Malignant-Like Behavior.

Journal: Advanced biology

Published: September 12, 2024

Feeder-free culture of human pluripotent stem cells drives MDM4-mediated gain of chromosome 1q.

Feeder-free culture of human pluripotent stem cells drives MDM4-mediated gain of chromosome 1q.

Journal: Stem cell reports

Published: May 24, 2024

Analysis of a mouse germ cell tumor model establishes pluripotency-associated miRNAs as conserved serum biomarkers for germ cell cancer detection.

Analysis of a mouse germ cell tumor model establishes pluripotency-associated miRNAs as conserved serum biomarkers for germ cell cancer detection.

Journal: Scientific reports

Published: May 20, 2024

Analysis of a mouse germ cell tumor model establishes pluripotency-associated miRNAs as conserved serum biomarkers for germ cell cancer detection.

Analysis of a mouse germ cell tumor model establishes pluripotency-associated miRNAs as conserved serum biomarkers for germ cell cancer detection.

Journal: bioRxiv : the preprint server for biology

Published: September 25, 2023

Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors.

Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 20, 2022

The Role of TP53 in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors.

The Role of TP53 in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors.

Journal: International journal of molecular sciences

Published: September 29, 2021

Paclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II Trial.

Paclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II Trial.

Journal: European urology open science

Published: September 09, 2021

Combining Hypermethylated RASSF1A Detection Using ddPCR with miR-371a-3p Testing: An Improved Panel of Liquid Biopsy Biomarkers for Testicular Germ Cell Tumor Patients.

Combining Hypermethylated RASSF1A Detection Using ddPCR with miR-371a-3p Testing: An Improved Panel of Liquid Biopsy Biomarkers for Testicular Germ Cell Tumor Patients.

Journal: Cancers

Published: August 16, 2021

Recurrence of a Mediastinal Germ-Cell Tumor as a Somatic-Type Malignancy: A Complex Case Report.

Recurrence of a Mediastinal Germ-Cell Tumor as a Somatic-Type Malignancy: A Complex Case Report.

Journal: International journal of molecular sciences

Published: July 22, 2021

Showing 1-12 of 47

Last Updated: 09/26/2026